The incidence, treatment and prognosis of cervical carcinoma in young women: A retrospective analysis of 4,975 cases in Japan

European Journal of Gynaecological Oncology

Volumn 31, Issue 1, 2010, Pages 37-43

  Kokawa, K ^a   Takekida, S ^b   Kamiura, S ^b   Kita, M ^c   Enomoto, T ^d   Kawaguchi, R ^e   Saito, J ^f   Horie, A ^g   Umesaki, N ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NARA MEDICAL UNIVERSITY   (Japan)

^f KANSAI MEDICAL UNIVERSITY   (Japan)

^g KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical carcinoma; Incidence; Prognosis; Young women

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; JAPAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CONIZATION;

ADENOCARCINOMA; ADULT; AGE FACTORS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; JAPAN; LYMPHATIC METASTASIS; PROGNOSIS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 77349107654     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Marugame T., Hamashima C.: "Mortality trend of uterine cancer in Japan 1960-2000". Jap. J. Clin. Oncol., 2004, 34, 55.
2. Ioka A., Tsukuma H., Ajiki W., Oshima A.: "Influence of age on cervical cancer survival in Japan". Jpn. J. Clin. Oncol., 2005, 35, 464.
3. Ioka A., Tsukuma H., Ajiki W., Oshima A.: "Trends in uterine cancer incidence in Japan 1975-98". Jpn. J. Clin. Oncol., 2003, 33, 645.
4. Marugame T., Matsuda T., Kamo K., Katanoda K., Ajiki W., Sobue T. et al.: "Cancer incidence and incidence rates in Japan in 2001 based on the date from 10 population-based cancer registries". Jpn. J. Clin. Oncol., 2007, 37, 884.
5. Meanwell C.A., Kelly K.A., Wilson S., Roginski C., Woodman C., Griffiths R., Blackledge G.: "Young age as a prognostic factor in cervical cancer: analysis of population based data from 10022 cases". Br. Med. J., 1988, 296, 386.
6. Ito T., Ishizuka T., Suzuki K., Ikoma Y., Saito J., Onuma M. et al.: "Cervical cancer in young Japanese women". Arch. Gynecol. Obstet., 2000, 264, 68.
7. Bulk S., Visser O., Rozendaal L., Verheijen R.H.M., Meijer C.J.L.M.: "Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women". Int. J. Cancer, 2005, 113, 1005.
8. Pamela G., Hai-Yen Sung, Sawaya G.F.: "Changes in cervical incidence after three decades of screening US women less than 30 years old". Obstet. Gynecol., 2003, 102, 765.
9. Hemminki K., Li X., Mutanen P.: "Age-incidence relationships and time trends in cervical cancer in Sweden". Eur. J. Epidemiol., 2001, 17, 323.
10. Liu S., Semenciw R., Probert A., Mao Y.: "Cervical cancer in Canada: Changing patterns in incidence and mortality". Int. J. Gynecol Cancer, 2001, 11, 24.
11. Murrell D.S., Helm C.W., Bourne H.: "Carcinoma of the cervix in women up to 35 years of age". Clin. Oncol., 1990, 2, 260.
12. Rutledge F.N., Mitchell M.F., Munsell M., Bass S., McGuffee V., Atkinson N.: "Youth as a prognostic factor in cancer of the cervix: a matched analysis". Gynecol. Oncol., 1992, 44, 1230.
13. Mariani L., Iacovelli A., Vincenzoni C., Diatallevi F.F., Atlante M., Lombardi A.: "Cervical cancer in young patients: Clinical and pathological variables". Int. J. Gynecol. Obstet., 1993, 41, 61.
14. Serur E., Fruchter R.G., Maiman M., McGuire J., Arrastia C.D., Gibbon D.: "Age, substance abuse, and survival of patients with cervical carcinoma". Cancer, 1995, 75, 1530.
15. Clark M.A., Naahas W., Marker R.J., Dodson M.G.. "Cervical cancer: women aged 35 and younger compared to women aged 36 and older". Am. J. Clin. Oncol., 1991, 14, 352.
16. Chen R.J., Lin Y.H., Chen C.A., Huang S.C., Chow S.N., Hsieh C.Y.: "Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan". Gynecol. Oncol., 1997, 73, 184.
17. Kosary C.: "FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina". Semin. Surg. Oncol., 1994, 10, 31.
18. Piver M.S., Rutledge F., Smith J.P.: "Five classes of extended hysterectomy for women with cervical cancer". Obstet. Gynecol., 1974, 44, 215.
19. Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., Heintz A.P.M. et al.: "Carcinoma of the cervix uteri". J. Epidemiol. Biostat., 2001, 6, 5.
20. Greer B.E., Koh W.J.: "Diagnosis and treatment of cervical carcinomas. ACOG practice bulletin". Int. J. Gynecol Obstet., 2002, 78, 79.
21. The report of tumor board of JSOG. Acta Obstet. et Gyn. Japonica, 2007, 59, 901.
22. Green J.A., Kirwan J.M., Tierney J.F., Symonds P., Frescol L., Collingwood M.M. et al.: "Survival and recurrence after concominant chemotherapy and radiotherapy for cancer of the uterine cervix: a systemic review and meta-analysis". Lancet, 2001, 358, 781.
23. Lukka H., Hirte H., Fyles A.: "Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer-a meta-analysis". Clin. Oncol., 2002, 14, 203.
24. Vermorken J.B.: "The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review". Int. J. Gynecol. Cancer, 1993, 3, 129.
25. Tierney J.: "Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomized trials". Eur. J. Cancer, 2003, 39, 2470.
26. Kokawa K., Mabuchi Y., Tanaka K., Yagi S., Yata C., Umesaki U.: "Apoptosis in cervical carcinoma after balloon occluded arterial infusion of anticancer drugs". Anticancer Res., 2006, 26, 1413.
27. Tanaka T., Kokawa K., Umesaki U.: "Preoperative chemotherapy with irinotecan and mitomycin for FIGO stage IIIb cervical squamous cell carcinoma: a pilot study". Eur. J. Gynaec. Oncol., 2005, 26, 605.
28. Sardi J.E., Giaroli A., Sananes C., Ferreira M., Soderini A., Bermundes A. et al.: "Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results". Gynecol Oncol., 1997, 67, 61.
29. Benedetti-Panici P., Greggi S., Colombo A., Amoroso M., Smaniotto D., Giannarelli D. et al.: "Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study". J. Clin. Oncol., 2002, 20, 179.
30. Kokawa K., Nishimura R., Fujii T., Umesaki N.: "Neoadjuvant chemotherapy with irinotecan and mitomycin-C for locally advanced squamous cell carcinoma of the uterine cervix". Anticaner Res., 2007, 27, 2721.
31. Napolitano C., Imperano F., Mossa B., Framarino M.L., Marziani R., Marzetti L.: "The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial". Eur. J. Gynecol. Oncol., 2002, 24, 51.
32. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systemic review and metaanalysis of individual patient data from 21 randomized trials. Eur. J. Cancer, 2003, 39, 2470.